The present invention relates to improved compositions for photodynamic therapy (PDT) for the selective destruction of malignant, diseased, or infected cells or infective agents without causing damage to normal cells. In an embodiment, the composition comprises a photosensitising agent coupled to a ligand, wherein the ligand selectively binds to a targeted receptor and comprises an isolated peptide molecule having less than 10 or 8 amino acids.
